China’s new five-year work plan has a familiar list of growth and energy targets, an emphasis on technology investments, and special concerns about resource constraints and corruption, says CFR’s Eli…

A new genetic technology has the potential to cure diseases and boost plant, insect, and human lives, but it also poses profound ethical questions.

To contain infectious disease outbreaks like Zika and Ebola, global health authorities must learn from past efforts to motivate the private and nonprofit sectors around problems of the poor, write CF…

China’s advancement in the pharmaceutical sector has major implications for global health but it remains constrained by governance and other factors, says CFR’s Yanzhong Huang.